We have surveyed 500+ Life Sciences executives from over 160 biopharma companies in 7 countries to identify the most significant challenges and barriers to maturity in developing a connected health portfolio. We also set out to understand the strategic objectives of biopharma companies and the governance structures required to support connected health, as well as to pinpoint the values and benefits that connected health products can bring to biopharma companies.
This webinar will provide an overview of the key results of our research, and a panel discussion with industry experts to discuss the consequences:
- How connected health is set to revolutionize healthcare and drive business value
- The top challenges that must be overcome to fulfill the ambitions of connected health
- The level of adoption of connected health among biopharma companies and the most promising use cases
- Key recommendations for how biopharma companies can close the maturity gap and scale their connected health portfolios.
If you want to learn what your peers think about the maturity of connected health and how they intend to unlock the value in connected health, please register for this webinar.
